SR-BI has further been linked to nasopharyngeal cancer [27], colorectal cancer [28], ovarian cancer [28] and most notably breast cancer [29, 30], a tumor strongly dependent on the synthesis of sexual hormones. Here, SCARB1 is linked to ovarian cancer.